# Adipose-derived Mesenchymal Stem Cells in Osteoarthritis

> **NCT03869229** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Medical University of Warsaw** · enrollment: 100 (estimated)

## Conditions studied

- Knee Osteoarthritis
- Hip Osteoarthritis
- Glenohumeral Osteoarthritis
- Osteoarthritis

## Interventions

- **BIOLOGICAL:** Intra-articular injection of ADMSC

## Key facts

- **NCT ID:** NCT03869229
- **Lead sponsor:** Medical University of Warsaw
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-04-05
- **Primary completion:** 2020-03-01
- **Final completion:** 2022-03-20
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2019-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03869229

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03869229, "Adipose-derived Mesenchymal Stem Cells in Osteoarthritis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03869229. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*